Literature DB >> 15699450

Synthetic salusins as cardiac depressors in rat.

Hajime Izumiyama1, Hiroyuki Tanaka, Koso Egi, Makoto Sunamori, Yukio Hirata, Masayoshi Shichiri.   

Abstract

Using bioinformatic analyses of full-length, enriched human cDNA libraries, we recently identified salusins, multifunctional related peptides ubiquitously expressed in major human tissues. Salusins cause transient and profound hypotension when injected intravenously to rats, the hypotensive effect of salusin-beta being especially striking. However, the mechanisms of this hypotensive action remain elusive. To determine whether salusins modulate cardiac function in rats, we studied serial changes of systemic hemodynamics and functions of isolated perfused working and nonworking hearts before and after salusin administration. Intravenous salusin-beta administration to intact anesthetized rats caused a temporary rapid, profound decrease in aortic blood flow concomitantly with hypotension and bradycardia without affecting systemic vascular resistance. Salusin-beta-induced hypotension and bradycardia were completely blocked by pretreatment with atropine, a muscarinic receptor antagonist, but not by propranolol. In isolated perfused working rat hearts, salusin-beta significantly decreased cardiac output, aortic flow, and stroke work. However, it did not affect coronary flow in isolated working and nonworking hearts. Our results indicate that salusins induce potent hypotension via negative inotropic and chronotropic actions. Salusin-beta promotes its actions by facilitating vagal outflows to the heart, whereas the negative inotropism of salusin-beta is also mediated via a direct myotropic effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699450     DOI: 10.1161/01.HYP.0000156496.15668.62

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis.

Authors:  Süleyman Serdar Koca; Metin Özgen; Bahar Işık; Mustafa Necati Dağlı; Bilal Üstündağ; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2014-03-01

2.  IS SALUSIN-ALPHA A NEW MARKER OF CARDIOVASCULAR DISEASE RISK IN HYPOTHYROIDISM?

Authors:  H Usta Atmaca; F Akbas
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

Review 3.  Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Authors:  Kengo Sato; Rena Watanabe; Fumiko Itoh; Masayoshi Shichiri; Takuya Watanabe
Journal:  Int J Hypertens       Date:  2013-10-22       Impact factor: 2.420

4.  Salusin-β as a powerful endogenous antidipsogenic neuropeptide.

Authors:  Noriko Suzuki-Kemuriyama; Tae Nakano-Tateno; Yuji Tani; Yukio Hirata; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

5.  Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide.

Authors:  Kazumi Fujimoto; Akinori Hayashi; Yoshio Kodera; Tatsuya Saito; Takuya Toki; Akifumi Ogawa; Yuji Kamata; Koji Takano; Hideki Katakami; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

6.  Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins.

Authors:  Masayoshi Shichiri; Daisuke Nonaka; Lyang-Ja Lee; Kenji Tanaka
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

7.  Knockdown of Salusin-β Improves Cardiovascular Function in Myocardial Infarction-Induced Chronic Heart Failure Rats.

Authors:  Yu Xu; Yan Pan; Xingxing Wang; Aidong Chen; Xinyu Tang; Xuanxuan Liu; Ying Han
Journal:  Oxid Med Cell Longev       Date:  2021-08-10       Impact factor: 6.543

8.  Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?

Authors:  Urszula Kołakowska; Elżbieta Kuroczycka-Saniutycz; Anna Wasilewska; Witold Olański
Journal:  Pediatr Nephrol       Date:  2014-09-23       Impact factor: 3.714

9.  Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats.

Authors:  Hong-Bao Li; Da-Nian Qin; Kang Cheng; Qing Su; Yu-Wang Miao; Jing Guo; Meng Zhang; Guo-Qing Zhu; Yu-Ming Kang
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

10.  Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.

Authors:  Kazumi Fujimoto; Akinori Hayashi; Yuji Kamata; Akifumi Ogawa; Takuya Watanabe; Raishi Ichikawa; Yoshitaka Iso; Shinji Koba; Youichi Kobayashi; Takatoshi Koyama; Masayoshi Shichiri
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.